3B Blackbio: 3B Blackbio Dx Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025

3B Blackbio Dx Limited reported earnings results for the second quarter and six months ended September 30, 2025. For the second quarter, the company reported sales was INR 339.02 million compared to INR 291.47 million a year ago. Revenue was INR 394.08 million compared to INR 325.84 million a year ago. Net income was INR 147.12 million compared to INR 146.47 million a year ago. Basic earnings per share from continuing operations was INR 17.55 compared to INR 17.35 a year ago. Diluted earnings per share from continuing operations was INR 17.55 compared to INR 17.35 a year ago. For the six months, sales was INR 561.37 million compared to INR 485.81 million a year ago. Revenue was INR 659.59 million compared to INR 557.09 million a year ago. Net income was INR 273.01 million compared to INR 257.75 million a year ago. Basic earnings per share from continuing operations was INR 32.31 compared to INR 30.54 a year ago. Diluted earnings per share from continuing operations was INR 32.31 compared to INR 30.54 a year ago.